Jennifer Peppe is a clinical researcher with more than 25 years of experience. As the Senior Vice President, Clinical Operations at Imago, she oversees all operational aspects of the global clinical development programs. Ms. Peppe is a founding employee of Imago.
Prior to joining Imago, Ms. Peppe joined FerroKin BioSciences in 2010 as Vice President, Clinical Operations at the time of Shire Pharmaceuticals acquisition of FerroKin in 2012.
Prior to joining FerroKin BioSciences, she was an Associate Director at Genzyme Corporation, where she worked for 12 years. While in clinical development at Genzyme, she managed Phase 1 through Phase 3 trials in various indications including: hypercholesterolemia, psoriasis, clostridium difficile-associated diarrhea (CDAD) and relapsing-remitting multiple sclerosis (MS). Within the CDAD program, she was the Global Study Lead responsible for oversight of two identical Phase 3 trials which were initiated in 16 countries at ~300 sites, enrolling greater than 1100 patients. Within the MS program, her responsibilities included cross functional team leadership for a global Phase 2 trial, as well as oversight of an expansive Risk Management Program. She began her clinical research career as consortium lead study coordinator at the Dana-Farber Cancer Institute where she spent five years working on a Phase 4 pediatric acute lymphoblastic leukemia trial.
Ms. Peppe received a Bachelor of Arts degree in psychology from Smith College.
What is Jennifer Peppe's net worth?
The estimated net worth of Jennifer Peppe is at least $5.36 million as of December 15th, 2022. Ms. Peppe owns 148,809 shares of Imago BioSciences stock worth more than $5,358,612 as of April 25th. This net worth approximation does not reflect any other assets that Ms. Peppe may own. Learn More about Jennifer Peppe's net worth.
How old is Jennifer Peppe?
Ms. Peppe is currently 53 years old. There are 4 older executives and no younger executives at Imago BioSciences. The oldest executive at Imago BioSciences is Dr. Hugh Young Rienhoff Jr., M.D., CEO & Director, who is 70 years old. Learn More on Jennifer Peppe's age.
How do I contact Jennifer Peppe?
Has Jennifer Peppe been buying or selling shares of Imago BioSciences?
Jennifer Peppe has not been actively trading shares of Imago BioSciences during the last ninety days. Most recently, Jennifer Peppe sold 119,422 shares of the business's stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $35.80, for a transaction totalling $4,275,307.60. Following the completion of the sale, the insider now directly owns 148,809 shares of the company's stock, valued at $5,327,362.20. Learn More on Jennifer Peppe's trading history.
Who are Imago BioSciences' active insiders?